CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

SHE:300765 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	872.08	3,770	2,196	1,244	1,139
Short-Term Investments	355.53	-	-	-	-
Trading Asset Securities	470.09	-	-	413.59	321.94
Cash & Short-Term Investments	1,698	3,770	2,196	1,658	1,461
Cash Growth	-54.97%	71.71%	32.43%	13.51%	1.77%
Accounts Receivable	559.76	560.78	716.75	508.94	303.96
Other Receivables	2.05	1.55	1.56	1.37	1.8
Receivables	561.81	562.32	718.31	510.31	305.76
Inventory	398.67	224.82	238.13	262	111
Other Current Assets	144.22	60.29	38.47	56.92	35.6
Total Current Assets	2,802	4,618	3,191	2,487	1,913
Property, Plant & Equipment	2,668	2,312	1,055	926.42	727.49
Long-Term Investments	264.45	267.07	253.49	243.19	235.87
Goodwill	-	-	-	-	3.47
Other Intangible Assets	225.21	231.59	50.42	52.81	55.21
Long-Term Deferred Tax Assets	21.61	17.36	18.88	12.5	10.39
Other Long-Term Assets	40.29	26.33	15.9	19.06	9.43
Total Assets	6,022	7,472	4,584	3,741	2,955
Accounts Payable	396.21	1,264	178.75	129.17	64.16
Accrued Expenses	64.59	66.11	66.24	54.57	25.1
Current Portion of Long-Term Debt	-	-	0.22	-	-
Current Portion of Leases	0.84	0.81	-	0.84	-
Current Income Taxes Payable	17.15	28.36	34.77	14.95	10.26
Current Unearned Revenue	18.68	19.8	68.26	30.37	25.27
Other Current Liabilities	936.82	524.42	234.52	178.75	109.46
Total Current Liabilities	1,434	1,904	582.77	408.64	234.24
Long-Term Debt	-	-	19.8	-	-
Long-Term Leases	-	0.84	-	-	-
Long-Term Unearned Revenue	90.49	84.16	37.21	34.27	33.31
Long-Term Deferred Tax Liabilities	1.4	0.02	0.06	0.67	0.45
Total Liabilities	1,526	1,989	639.84	443.58	268
Common Stock	1,405	1,171	618.93	546	420
Additional Paid-In Capital	977.27	2,125	1,138	1,211	882.28
Retained Earnings	1,667	1,988	2,177	1,533	1,376
Treasury Stock	-321.03	-4.25	-	-	-
Comprehensive Income & Other	2.5	1.98	0.72	-1.2	-0.1
Total Common Equity	3,731	5,281	3,936	3,289	2,678
Minority Interest	765.39	202.45	8.59	8.26	8.79
Shareholders' Equity	4,496	5,483	3,944	3,298	2,687
Total Liabilities & Equity	6,022	7,472	4,584	3,741	2,955
Total Debt	0.84	1.65	20.02	0.84	-
Net Cash (Debt)	1,697	3,769	2,176	1,657	1,461
Net Cash Growth	-54.97%	73.21%	31.29%	13.45%	1.77%
Net Cash Per Share	1.21	2.70	1.63	1.24	1.24
Filing Date Shares Outstanding	1,393	1,405	1,337	1,179	1,179
Total Common Shares Outstanding	1,393	1,405	1,337	1,179	1,179
Working Capital	1,368	2,714	2,608	2,079	1,679
Book Value Per Share	2.68	3.76	2.94	2.79	2.27
Tangible Book Value	3,505	5,049	3,885	3,237	2,619
Tangible Book Value Per Share	2.52	3.59	2.91	2.74	2.22
Buildings	1,020	973.56	609.24	430.75	397.71
Machinery	1,939	1,821	925.79	701.65	475.66
Construction In Progress	620.23	228.71	70.74	294.97	154.83

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.